Ophthalmic formulations containing substituted gamma lactams and methods for use thereof

Details for Australian Patent Application No. 2010315051 (hide)

Owner Allergan, Inc.

Inventors Gore, Anuradha; Jordan, Robert S.; Parashar, Ajay P.; Pujara, Chetan P.; Graham, Richard S.; Lee, Mu-Lan

Agent Davies Collison Cave

Pub. Number AU-A-2010315051

PCT Pub. Number WO2011/057108

Priority 61/258,308 05.11.09 US

Filing date 5 November 2010

Wipo publication date 12 May 2011

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 31/4025 (2006.01) - not condensed and containing further heterocyclic rings, e.g. cromakalim

A61K 47/10 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Alcohols

A61K 47/26 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carbohydrates

A61P 27/06 (2006.01) Drugs for disorders of the senses

Event Publications

31 May 2012 PCT application entered the National Phase

  PCT publication WO2011/057108 Priority application(s): WO2011/057108

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010315057-Catenae: serosal cancer stem cells

2010315047-Solid state positive force touch sensing